ZNF217 and breast neoplasm: Using a primer pair targeting exon 3, we have previously demonstrated that the ZNF217 mRNA expression level of a breast tumor is informative and provides a powerful biomarker of poor prognosis, in particular in the Luminal subclass (5, 7).